WordNet

any of a large variety of proteins normally present in the body or produced in response to an antigen which it neutralizes, thus producing an immune response

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 抗GBM抗体（グッドパスチャー）病の病因および診断 pathogenesis and diagnosis of anti gbm antibody goodpastures disease
2. 免疫グロブリンの機能および臨床応用 function and clinical applications of immunoglobulins
3. 薬剤の効きづらい高コレステロール血症の治療 treatment of drug resistant hypercholesterolemia
4. 慢性C型肝炎ウイルス感染のスクリーニングおよび診断 screening for and diagnosis of chronic hepatitis c virus infection
5. 抗GBM抗体（グッドパスチャー）病の治療 treatment of anti gbm antibody goodpastures disease

Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.

Umekita K, Hidaka T, Miyauchi S, Ueno S, Kubo K, Takajo I, Hashiba Y, Kai Y, Nagatomo Y, Okayama A.
Arthritis care & research.Arthritis Care Res (Hoboken).2014 May;66(5):788-92.
OBJECTIVE: To investigate the response to and safety of anti–tumor necrosis factor (anti-TNF) therapy in human T lymphotropic virus type I (HTLV-I)–positive patients with rheumatoid arthritis (RA).METHODS: Therapeutic response was evaluated in 10 HTLV-I–positive and 20 HTLV-I–negative patien
PMID 24127184

Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G.
Emerging infectious diseases.Emerg Infect Dis.2014 May;20(5):772-82. doi: 10.3201/eid2005.131298.
Bovine leukemia virus (BLV), a deltaretrovirus, causes B-cell leukemia/lymphoma in cattle and is prevalent in herds globally. A previous finding of antibodies against BLV in humans led us to examine the possibility of human infection with BLV. We focused on breast tissue because, in cattle, BLV DNA
PMID 24750974

Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Chang YB1, Kaidarova Z, Hindes D, Bravo M, Kiely N, Kamel H, Dubay D, Hoose B, Murphy EL.
The Journal of infectious diseases.J Infect Dis.2014 Feb 15;209(4):523-31. doi: 10.1093/infdis/jit497. Epub 2013 Sep 24.
BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) and HTLV-2 are prevalent at low levels among US blood donors, but recent data on their prevalence is lacking. METHODS. Data on all first-time blood donors in a large network of US blood centers were examined during 2000-2009. HTLV-1 and HTLV-2 a
PMID 24068702